IHAM
AXSM icon

Integral Health Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Integral Health Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.92M Buy
+35,000
New +$6.05M 0.28% 74
2024
Q2 		– Sell
-30,000
Closed -$2.39M – 81
2024
Q1 		$2.39M Buy
+30,000
New +$2.52M 0.22% 79

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Integral Health Asset Management's AXSM Position: Q1 2026 in Review

Integral Health Asset Management opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 35,000 shares worth $5.92M. The stake represents 0.28% of the portfolio and ranks #74 among its holdings. This is a return to the name: Integral Health Asset Management previously reported a position in AXSM as recently as Q1 2024.

Integral Health Asset Management first reported a position in AXSM in Q1 2024 and has held it in 2 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Integral Health Asset Management held 35,000 shares of Axsome Therapeutics worth $5.92M as of Q1 2026.
  • Axsome Therapeutics was a new Integral Health Asset Management position in Q1 2026.
  • Axsome Therapeutics made up 0.28% of Integral Health Asset Management's portfolio in Q1 2026, its #74 holding.
  • Integral Health Asset Management first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 2 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.